Tag Archives: Vitamin D
Evidence-based prevention of Alzheimer’s disease: systematic review
Results A total of 44 676 reports were identified, and 243 OPSs and 153 RCTs were eligible for analysis after exclusion based on pre-decided criteria, from which 104 modifiable factors and 11 interventions were included in the meta-analyses. Twenty-one suggestions are proposed based on the consolidated evidence, with Class I suggestions targeting 19 factors: 10 with Level A strong evidence (education, cognitive activity, high body mass index in latelife, hyperhomocysteinaemia, depression, stress, diabetes, head trauma, hypertension in midlife and orthostatic hypotension) and 9 with Level B weaker evidence (obesity in midlife, weight loss in late life, physical exercise, smoking, sleep, cerebrovascular disease, frailty, atrial fibrillation and vitamin C). In contrast, two interventions are not recommended: oestrogen replacement therapy (Level A2) and acetylcholinesterase inhibitors (Level B). Continue reading
Vitamin-D and COVID-19: do deficient risk a poorer outcome?
Source: DOI:https://doi.org/10.1016/S2213-8587(20)30183-2 “Despite difficulties in comparing data across nations, mortality from COVID-19 is clearly higher in some countries than in others. Many factors could have a role in this disparity, including differences in proportion of elderly people in a population, … Continue reading
Eastern and Western Medicine Integration – A Conversation with Jin Shin Institute’s Alexis Brink
LinkLive HAPPENING RIGHT NOW!!! Sitting down with Alexis Brink and Maurice Preter MD Psychiatry and Neurology ???? You can find Maurice Preter, M.D. at https://psychiatryneurology.net/ and on his Facebook page (linked above). #LinkLiveJSI Posted by Jin Shin Institute on Monday, … Continue reading
Dementia and Alzheimers’ Disease – How Can It Be Treated?
Dementia and Alzheimers’ Disease – How Can It Be Treated?
The Latin word “De-mentia”, literally means, the removal of a person from their own mind. It stands for a significant decrease in brain function, including memory, goal-directed thinking, orientation in space and time, and language ability.
Most dementias are progressive. They cannot be cured and will gradually cause more severe problems for the patient, and for the patient’s caretakers. As the population ages, Alzheimer’s disease is on its way to becoming the third most common fatal disease.
Prescription medications on the market starting in the 1990s to treat dementia have been a disappointment to patients and doctors alike.
The frustration caused by this situation prompted me to make the development of an anti-dementia treatment protocol a major focus of my clinical work.
As always, we start with a thorough neuropsychiatric assessment, looking for potentially reversible causes of cognitive decline such as a thyroid condition, vitamin deficiency, a sleep disorder, elevated blood sugar and diabetes. Importantly, untreated depression and chronic high stress and anxiety levels are associated with a higher risk for dementia. Most of the time, psychotherapy is a far better alternative to the all-too-common multiple prescription drugs.
The protocol uses a number of carefully evaluated novel interventions and components based on sound neuroscientific principles, sourced from both functional medicine and traditional medical systems, such as Ayurvedic and traditional Chinese medicine.
The protocol stabilizes many of my patients, and improves their functioning and quality of life. It has shown promising results not only for dementia, but also for traumatic brain injury. Continue reading